Swiss Re (VTX:SREN) PT Set at CHF 120 by JPMorgan Chase & Co.
Several other research firms have also recently issued reports on SREN. Goldman Sachs Group reaffirmed a buy rating and set a $70.00 price target on shares of Total in a research note on Monday, July 15th. Royal Bank of Canada reaffirmed a sell rating on shares of Intel in a research note on Monday, July 15th. Deutsche Bank reaffirmed a hold rating and set a GBX 1,775 ($23.19) price target on shares of in a research note on Wednesday, June 26th. UBS Group raised shares of to a neutral rating and raised their price target for the stock from GBX 945 ($12.35) to GBX 2,060 ($26.92) in a research note on Thursday, June 20th. Finally, HSBC decreased their price target on shares of Canada Goose from C$62.00 to C$55.00 and set a buy rating on the stock in a research note on Monday, June 3rd. One analyst has rated the stock with a sell rating, four have issued a hold rating and eight have given a buy rating to the company’s stock. The stock has a consensus rating of Buy and an average target price of CHF 105.67.
Swiss Re has a 12 month low of CHF 81.65 and a 12 month high of CHF 98.80.
Swiss Re AG is a wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer. The Company operates in four segments: Property&Casualty Reinsurance, Life&Health Reinsurance, Corporate Solutions and Life Capital. Its Reinsurance Unit provides premiums and fee income through Property&Casualty and Life&Health segments.
Featured Story: Compound Interest and Why It Matters When Investing
Receive News & Ratings for Swiss Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Swiss Re and related companies with MarketBeat.com's FREE daily email newsletter.